Global Markets Direct
Global Markets Direct Market Research Reports
| Title | published | price | |
|---|---|---|---|
Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Drugs In De ... |
30-Sep-2022 | $2500 | |
Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Drugs In ... |
30-Sep-2022 | $2000 | |
Cryptosporidiosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Cryptosporidiosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptosporidiosis - D ... |
30-Sep-2022 | $2000 | |
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Malaria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, ... |
30-Sep-2022 | $2500 | |
Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis ... |
30-Sep-2022 | $2000 | |
Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Drugs In Deve ... |
30-Sep-2022 | $2500 | |
Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Cytomegalovirus (HHV-5) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cyto ... |
30-Sep-2022 | $2000 | |
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7. ... |
30-Sep-2022 | $3500 | |
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glycogen Sy ... |
30-Sep-2022 | $3500 | |
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Protein K ... |
30-Sep-2022 | $3500 | |
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Complement C5 (C3 And PZP Like Alph ... |
30-Sep-2022 | $3500 | |
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Transthyretin is a tr ... |
30-Sep-2022 | $3500 | |
Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Catenin Beta 1 (Beta Catenin or CTNNB1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Catenin Beta 1 - Drugs In Development, ... |
30-Sep-2022 | $3500 | |
Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Glycoprotein 41 (gp41) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Glycoprotein 41 (gp41) pipeline Target constitutes close to 19 molecules. Out of which approximately ... |
30-Sep-2022 | $3500 | |
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary 20s Proteasome - 20S proteasome is the catalytic core of the 26S proteasome, the central protease of the ubi ... |
30-Sep-2022 | $3500 | |
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published rep ... |
30-Sep-2022 | $3500 | |
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline ... |
30-Sep-2022 | $3500 | |
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid ... |
30-Sep-2022 | $3500 | |
Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Glucagon Like Peptide 2 Receptor (GLP2R) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report 'Glucagon Like Peptide 2 Receptor - Dru ... |
30-Sep-2022 | $3500 | |
Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct
Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Drugs In Deve ... |
30-Aug-2022 | $2000 | |
- + 1 888 391 5441
- [email protected]
